http://jcps.bjmu.edu.cn
Prof. Xinjing Tang and Dr. Qian Wang developed a miRNA-based PROTACs strategy to target the degradation of Lin28 protein for the combined breast cancer therapy
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
Journal of Chinese Pharmaceutical Sciences . 2024, (9): 875 -876 . 

About Journal | Info for Authors | Statements | Peer Review Policy | Submission | Copyright Info
京ICP备05051953号-7
Copyright © Journal of Chinese Pharmaceutical Sciences, School of Pharmaceutical Sciences, Peking University
Tel./Fax: +86-10-82801713, E-mail: jcps@bjmu.edu.cn
Powered by Beijing Magtech Co., Ltd.